Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 18, 2022

Edoxaban vs DAPT for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR



Additional Info

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial
Circulation 2022 Apr 04;[EPub Ahead of Print], DW Park, JM Ahn, DY Kang, KW Kim, HJ Koo, DH Yang, SC Jung, B Kim, YTA Wong, CCS Lam, WH Yin, J Wei, YT Lee, HL Kao, MS Lin, TY Ko, WJ Kim, SH Kang, SC Yun, SA Lee, E Ko, H Park, DH Kim, JW Kang, JH Lee, SJ Park

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading